Argá Medtech today announced it closed a €54 million oversubscribed Series B funding round to support its pulsed field ablation technology. The Lausanne, Switzerland-based company develops the Coherent Sine-Burst Electroporation pulsed field ablation system for treating cardiac arrhythmias, including atrial fibrillation. Argá’s latest financing will allow the company to advance the development of its CSE […]